Neurologic and immunologic effects of exposure to corticosterone, chlorpyrifos, and multiple doses of tri-ortho-tolyl phosphate over a 28-day period in rats

Journal of Toxicology and Environmental Health - Part A

Volumn 67, Issue 5, 2004, Pages 431-457

  Ehrich, M ^a   Hancock, S ^a   Ward, D ^a   Holladay, S ^a   Pung, T ^a   Flory, L ^a   Hinckley, J ^a   Jortner, B S ^a  

^a VIRGINIA MARYLAND REGIONAL COLLEGE OF VETERINARY MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; CARBOXYLESTERASE; CHLORPYRIFOS; CHOLINE ACETYLTRANSFERASE; CHOLINESTERASE; CORTICOSTERONE; DRINKING WATER; ESTERASE; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTATHIONE PEROXIDASE; NEUROTOXIC ESTERASE; ORGANOPHOSPHATE INSECTICIDE; SUPEROXIDE DISMUTASE; TRI ORTHO CRESYL PHOSPHATE; TRICRESYL PHOSPHATE;

AMBULATORY MONITORING; ANIMAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; BLOOD; BLOOD ANALYSIS; BODY WEIGHT; BRAIN; BRAIN CORTEX; BRAIN REGION; CELL DAMAGE; CHOLINESTERASE BLOOD LEVEL; CONTROLLED STUDY; DOSE RESPONSE; DRINKING; DRUG ADMINISTRATION; DRUG EFFECT; ENVIRONMENTAL EXPOSURE; ENZYME ACTIVITY; ENZYMOLOGY; FOREBRAIN; FUNCTIONAL ASSESSMENT; GRIP STRENGTH; HIPPOCAMPUS; IMMUNOTOXICITY; LIVER; MALE; METABOLISM; MOBILIZATION; MOTOR ACTIVITY; MYELINATED NERVE; NERVE DEGENERATION; NERVE FIBER; NERVE FIBER DEGENERATION; NEUROLOGIC EXAMINATION; NEUROTOXICITY; NONHUMAN; PASSIVE AVOIDANCE; PATHOLOGY; PRIORITY JOURNAL; PUTAMEN; RAT; RAT STRAIN; SPLEEN CELL; STRESS; THYMOCYTE; TISSUE DISTRIBUTION; WEIGHT REDUCTION;

ANIMALIA; VERTEBRATA;

EID: 1242297819     PISSN: 15287394     EISSN: 10872620     Source Type: Journal    
DOI: 10.1080/15287390490273497     Document Type: Article

References (56)

1. Angelucci, L. 2000. The glucocorticoid hormone: From pedestal to dust and back. Eur. J. Pharmacol. 405:139-147.
2. Baker, T., Drakontides, A. B., and Riker, W. F. 1982. Prevention of the organophosphorus neuropathy by glucocorticoids. Exp. Neurol. 78:397-408.
3. Brank, M., and Grubic, Z. 1993. The influence of chronic treatment with dexamethasone on the acetylcholinesterase activity in rat skeletal muscle. Chem. Biol. Interact. 87:249-252.
4. Carlson, K., Jortner, B. S., and Ehrich, M. 2000. Organophosphorus compound-induced apoptosisin SH-SY5Y human neuroblastoma cells. Toxicol. Appl. Pharmacol. 168:102-113.
5. Chambers, H. W., and Chambers, J. E. 1989. An investigation of acetylcholinesterase inhibition and aging and choline acetyltransferase activity following a high level acute exposure to paraoxon. Pest. Biochem. Physiol. 33:125-131.
6. Clark, P. G. H. 1999. Apoptosis versus necrosis: How valid a dichotomy for neurons? In Cell death and diseases of the nervous system, eds. V. E. Koliatsos, and R. R. Ratan, pp. 3-28. Philadelphia: Humana Press.
7. Clegg, D. J., and van Gemert, M. 1999a. Determination of the reference dose for chlorpyrifos: Proceedings of an expert panel. J. Toxicol. Environ. Health 2:211-255.
8. Clegg, D. J., and van Gemert, M. 1999b. Expert panel report of human studies on chlorpyrifos and/or other organophosphate exposures. J. Toxicol. Environ. Health B 2:257-279.
9. Correll, L., and Ehrich, M. 1991. A microassay method for neurotoxic esterase. Fundam. Appl. Toxicol. 11:110-116.
10. Daughtrey, W., Biles, R., Jortner, B., and Ehrich, M. 1996. Subchronic delayed neurotoxicity evaluation of jet engine lubricants containing phosphorus additives. Fundam. Appl. Toxicol. 32:244-249.
11. Drakinotides, A. B., Baker, T., and Riker, W. F., Jr. 1982. A morphological study of the effect of glucocorticoid treatment on delayed organophosphorus neuropathy. Neurotoxicology 3:165-178.
12. Dyck, P. G., Giannini, C., and Lais, A. 1993. Pathologic alterations of nerve. In Peripheral neuropathy, eds. P. J. Dyck, P. K. Thomas, J. W. Griffin, P. A. Low, and J. F. Poduslo, pp. 514-595. Philadelphia: W. B. Saunders.
13. Dyer, K., Jortner, B. S., Shell, L. G., and Ehrich, M. 1992. Comparative dose-response studies of organo-phosphorus ester-induced delayed neuropathy in hens and rats administered mipafox. Neurotoxicology 13:745-756.
14. Ecobichon, D. J. 1994. Organophosphorus ester insecticides. In Pesticides and neurological diseases, eds. D. J. Ecobicon and R. M. Joy, pp. 171-249. Boca Raton, FL: CRC Press.
15. Ehrich, M., and Gross, W. B. 1983. Modification of TOTP toxicity in chickens by stress. Toxicol. Appl. Pharmacol. 70:245-254.
16. Ehrich, M., and Gross, W. B. 1986. Effect of supplemental corticosterone and social stress on organophosphorus-induced delayed neuropathy in chickens. Toxicol. Lett. 31:9-13.
17. Ehrich, M., and Jortner, B. S. 2001. Organophosphorus induced delayed neuropathy. In Handbook of pesticide toxicology, ed. R. Kreiger, pp. 987-1012. San Diego: Academic Press.
18. Ehrich, M., Jortner, B. S., and Padilla, S. 1995. Comparison of the relative inhibition of acetylcholinesterase and neuropathy target esterase in rats and hens given cholinesterase inhibitors. Fundam. Appl. Toxicol. 24:94-101.
19. Ehrich, M., Shell, L., Rozum, M., and Jortner, B. S. 1992. Short-term clinical and neuropathological effects of cholinesterase inhibitors in rats. J. Am. Coll. Toxicol. 12:55-68.
20. Friedman, E. M., and Lawrence, D. A. 2002. Environmental stress mediates changes in neuroimmunological interactions. Toxicol. Sci. 67:4-10.
21. Gabriel, N. N., and Soliman, K. F. A. 1983. Effect of stress on the acetylcholinesterase activity of the hypothalamus-pituitary-adrenal axis in the rat. Hormone Res. 17:43-48.
22. Gallo, M. A., and Lawryk, N. J. 1991. Organic phosphorus pesticides. In Handbook of pesticide toxicology, eds. W. J. Hayes, Jr., and E. R. Laws, Jr., pp. 917-1123. San Diego: Academic Press.
23. Griffin, W. S. T., and Stanley, L. C. 1993. Glial activation as a common denominator in neurodegenerative disease: A hypothesis in neuropathophysiology. In Biology and pathology of astrocyte-neuron interactions, ed. S. Fedoroff, pp. 359-381. New York: Plenum Press.
24. Institute of Medicine. 2000. Gulf War and health, Vol. 1, Depleted uranium, pyridostigmine bromide, sarin, vaccines. Washington, DC: National Academy of Sciences.
25. Institute of Medicine. 2003. Gulf War and health, Vol. 2, Insecticides and solvents. Washington DC: National Academy of Sciences.
26. Johnson, M. J. 1990. Organophosphates and delayed neuropathy—Is NTE alive and well? Toxicol. Appl. Pharmacol. 102:385-399.
27. Jortner, B. J. 1988. Organophosphorus ester-induced delayed neuropathy, rat. In Monographs on pathology of laboratory animals—nervous system, eds. T. C. Jones, R. Mohr, and R. D. Hunt, pp. 41-47. New York: Springer Verlag.
28. Jortner, B. J. Hancock, S., Hinckley, J., Florey, L., and Ehrich, M. 2003. Neuropathological study of the interactions of stress and two neurotoxic organophosphates in rats. Toxicol. Sci. 72S:305.
29. Kauger, D., Friedman, A., Seidman, S., and Soreq, H. 1998. Acute stress facilitates long-lasting change in cholinergic gene expression. Nature 393:373-377.
30. Kodavanti, P. R. S. 1999. Reactive oxygen species and antioxidant homeostasis in neurotoxicology. In Neurotoxicology, 2nd ed., eds. H. A. Tilson and G. J. Harry, pp. 157-178. Philadelphia: Taylor & Francis.
31. Lotti, M. 2001. Clinical toxicology of anticholinesterase agents in humans. In Handbook of pesticide toxicology, ed. R. Kreiger, pp. 1043-1085. San Diego: Academic Press.
32. Luster, M. I., Germolec, D. R., Clark, G., Wiegand, G., and Rosenthal, G. J. 1988. Selective effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin and corticosteroid on in vitro lymphocyte maturation. J. Immunol. 140:928-935.
33. Luster, M. I., Portier, C., Pair, D. G., White, K. L., Jr., Gennings, C., Munson, A. E., and Rosenthal, G. J. 1992. Risk assessment in immunotoxicology, I: Sensitivity and predictability of immune tests. Fundam. Appl. Toxicol. 18:200-210.
34. Magarinos, A. M., Orchinik, M., and McEwen, B. S. 1998. Morphological changes in the hippocampal CA3 region induced by non-invasive glucocorticoid administration: A paradox. Brain Res. 809:314-318.
35. McEwen, B. S. 2000. Effects of adverse experiences for brain structure and function. Biol. Psychiatry 48:721-731.
36. McEwen, B. S., and Magarinos, A. M. 2001. Stress and hippocampal plasticity: Implications for the pathophysiology of affective disorders. Hum. Psychopharmacol. 16:57-518.
37. Moser, V. C., McCormick, J. P., Creason, J. P., and MacPhail, R. C. 1988. Comparison of chlordimeform a and carbaryl using a functional observational battery. Fundam. Appl. Toxicol. 11:189-206.
38. O'Callaghan, J. P. 2002. Measurement of glial fibrillary acidic protein. In Current protocols in toxicology, ed. M. D. Maines, pp. 12.8.1-12.8.12. New York: John Wiley & Sons.
39. O'Callaghan, J. P., Brinton, R. E., and McEwen, B. S. 1991. Glucocorticoids regulate the synthesis of glial fibrillary acidic protein in intact and adrenalectomized rats but do not affect its expression following brain injury. J. Neurochem. 57:860-869.
40. Paxinos, G. 1995. The rat nevous system, 2nd ed. San Diego: Acadmic Press.
41. Paxinos, G., and Watson, C. 1986. The rat brain in stereotaxic coordinates, 2nd ed. San Diego: Academic Press.
42. Pruett, S. B., Ensley, D. K., and Crittenden, P. L. 1993. The role of chemical-induced stress responses in immunosuppression: A review of quantitative associations and cause-effect relationships between chemical-induced stress responses and immunosuppression. J. Toxicol. Environ. Health 39:163-192.
43. Pung, T., Zimmerman, K., Moore, D., Fuhrman, K., and Ehrich, M. 2003. Corticosterone in drinking water altered the time and plasma concentration curve of a single oral dose of corticosterone and levels of plasma sodium, albumin, globulin and total protein. Toxicol. Sci. 72S:146.
44. Richardson, R. J. 1995. Assessment of the neurotoxic-potential of chlorpyrifos relative to other organo-phosphorus compounds: A critical review of the literature. J. Toxicol. Environ. Health 44:135-165.
45. Sapolsky, R. M. 2000. Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Arch. Gen. Psychiatry, 47:925-935.
46. Sapolsky, R. M., Romero, L. M., and Munck, A. U. 2000. How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory and preparative actions. Endocr. Rev. 2:55-89.
47. Schmued, L. C., and Hopkins, K. J. 2000. Fluoro-Jade: Novel fluorochromes for detecting toxicant-induced neuronal degeneration. Toxicol. Pathol. 28:91-99.
48. Smialowicz, R. J., Riddle, M. M., Williams, W. C., and Diliberto, J. J. 1994. Effects of 2,3,7,8-tetrachloro-dibenzo-p-dioxin (TCDD) on humoral immunity and lymphocyte subpopulations: Differences between mice and rats. Toxicol. Appl. Pharmacol. 124:248-256.
49. Stam, R., Bruijnzeel, A. W., and Wiegant, V. M. 2000. Long-lasting stress sensitization. Eur. J. Pharmacol. 405:217-224.
50. U.S. Environmental Protection Agency. 1998. Health effects test guidelines OPPTS 870.6100, Acute and 28-day delayed neurotoxicity of organophosphorus substances. Health effects test guidelines OPPTS 870.6200, Neurotoxicity screening battery. Available from U.S. EPA web site http:///www.epa.gov/ epahome/research.htm under the heading Researchers and Scientists/Test Methods and Guidelines/ OPPTS Harmonized Test Guidelines.
51. Varjee, Z. H., Behal, R., and Ayim, E. M. 1977. Effect of glucocorticoids on liver and blood cholinesterases. Clin. Chim. Acta 81:41-46.
52. Veronesi, B. 1984. A rodent model of organophosphorus-induced delayed neuropathy: Distribution of central (spinal cord) and peripheral nerve damage. Neuropathol. Appl. Neurobiol. 10:357-368.
53. Weiner, M. L., and Jortner, B. J. 1999. Organophosphate-induced delayed neurotoxicity of triarylphos-phates. Neurotoxicology 20:653-674.
54. Wilson, B. W. 2001. Cholinesterases. In Handbook of pesticide toxicology, ed. R. Kreiger, pp. 967-985. San Diego: Academic Press.
55. Wilson, B. W., Padilla, S., Henderson, J. D., Brimijoin, S., Dass, P. D., Elliot, G., Jaeger, B., Lanz, D., Pearson, R., and Spies, R. 1996. Factors in standardizing automated cholinesterase assays. J. Toxicol. Environ. Health 48:187-195.
56. Young, E. A., Kwak, S. P., and Kottak, J. 1995. Negative feedback regulation following administration of chronic exogenous corticosterone. J. Neuroendocrin. 7:37-45.